Citation
Daud Ahmad Israf Ali
(2012)
Use of the curcumin analog BHMC in the treatment of endothelial dysfunction and related disorders.
PI2012003491.
Abstract
The present invention relates to an analog of curcumin, 2,6-bis-(4-hydroxyl-3-methoxybenzylidine)cyclohexanone (BHMC) or a pharmaceutically acceptable salt, solvate or derivative thereof, for use in treating, preventing or managing endothelial dysfunction and/or a disorder associated with endothelial dysfunction. Furthermore provided are methods of treating, preventing or managing endothelial dysfunction and/or a disorder associated with endothelial dysfunction using BHMC or a pharmaceutically acceptable salt, solvate or derivative thereof. The invention provides also a method for attenuating endothelial dysfunction in an endothelial cell and/or attenuating the hallmarks of endothelial dysfunction in an endothelial cell.
Download File
Full text not available from this repository.
|
Additional Metadata
| Item Type: | Patent |
|---|---|
| Application Number: | PI2012003491 |
| Filing Date: | 2012-08-02 |
| Divisions: | Faculty of Veterinary Medicine |
| Keywords: | Curcumin analog; BHMC; Pharmaceutically acceptable salt; Endothelial dysfunction |
| Depositing User: | Nurul Ainie Mokhtar |
| Date Deposited: | 05 Feb 2015 04:21 |
| Last Modified: | 05 Feb 2015 04:21 |
| URI: | http://psasir.upm.edu.my/id/eprint/33360 |
| Statistic Details: | View Download Statistic |
Actions (login required)
 |
View Item |